Revive Therapeutics Ltd. Annual cash flow by MarketWatch. View RVVTF net cash flow, operating cash flow, operating expenses and cash dividends.
The USPTO has granted Revive Therapeutics' (OTCQB:RVVTF) Patent No. 10,104,888, titled "Tannin-chitosan composites". This patent expands Revive’s coverage for the delivery of cannabinoids in various ...
Revive Therapeutics Ltd. engages in the research, development, and commercialization of drugs for disorders and infectious diseases. The company was founded by Fabio Chianelli on March 27, 2012 and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results